Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?
- PMID: 34495381
- PMCID: PMC8424403
- DOI: 10.1007/s00259-021-05553-3
Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?
Conflict of interest statement
The authors declare no competing interests.
References
-
- EMA recommends COVID-19 vaccine Moderna for authorisation in the EU. European Medicines Agency. 2021
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical